CuraSen Therapeutics: Funding, Investors & Team (Oct 2026)
It's time to reconsider neurodegenerative disease treatments. At CuraSen, we use cutting-edge research and therapies to combat neurodegeneration so that patients may THINK, AGAIN. A privately funded biopharmaceutical business called CuraSen Therapeutics, Inc. is working to create novel medicines for a number of orphan indications as well as neurodegenerative disorders like Parkinson's and Alzheimer's. These illnesses afflict millions of patients and their families, and the numbers keep rising each year as the population ages. At CuraSen, we are developing a concept based on restoring a crucial capability to a route lost at an early stage in the degenerating brain in order to cure neurodegenerative illnesses.
CuraSen Therapeutics has raised $44.6M across 4 funding rounds on record, the most recent an undisclosed round of $5.8M announced in Sep 2024.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
CuraSen Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2024.
CuraSen Therapeutics Funding Rounds
CuraSen Therapeutics raised $18.0M in an undisclosed round announced in Nov 2021.
1 years later, an undisclosed round of $15.0M was announced in Nov 2022.
11 months later, an undisclosed round of $5.8M was announced in Oct 2023.
11 months later, an undisclosed round of $5.8M was announced in Sep 2024.
CuraSen Therapeutics Founders and Leadership Team
Contact details for the CuraSen Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →CuraSen Therapeutics Funding Compared to Other Biotechnology Startups
CuraSen Therapeutics' latest round of $5.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CuraSen Therapeutics in Biotechnology and San Carlos
Companies Similar to CuraSen Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
CuraSen Therapeutics Funding FAQs
What does CuraSen Therapeutics do?
It's time to reconsider neurodegenerative disease treatments. At CuraSen, we use cutting-edge research and therapies to combat neurodegeneration so that patients may THINK, AGAIN. A privately funded biopharmaceutical business called CuraSen Therapeutics, Inc. is working to create novel medicines for a number of orphan indications as well as neurodegenerative disorders like Parkinson's and Alzheimer's. These illnesses afflict millions of patients and their families, and the numbers keep rising each year as the population ages. At CuraSen, we are developing a concept based on restoring a crucial capability to a route lost at an early stage in the degenerating brain in order to cure neurodegenerative illnesses.
How much funding has CuraSen Therapeutics raised?
CuraSen Therapeutics has raised $44.6M across 4 rounds on record. The most recent is an undisclosed round of $5.8M announced in Sep 2024.
When did CuraSen Therapeutics last raise funding?
CuraSen Therapeutics' most recent funding round on record is an undisclosed round of $5.8M, announced in Sep 2024.
Who founded CuraSen Therapeutics?
FundedIQ lists Anthony P Ford (Founder), Kathleen Sereda Glaub (Founder) at CuraSen Therapeutics.
Where is CuraSen Therapeutics headquartered?
CuraSen Therapeutics is based in San Carlos, California, United States.
How many employees does CuraSen Therapeutics have?
CuraSen Therapeutics is in the 11-50 employee band.
How does CuraSen Therapeutics' funding compare to other Biotechnology startups?
CuraSen Therapeutics' latest round of $5.8M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's CuraSen Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CuraSen Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.